Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders

doi:10.4254/wjh.v13.i12.1828

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 12

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9103)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

1094

WORD

219

HTML

6147

Figures (1-1)

294

Tables (1-2)

240

Sum=7994

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

395

Download

714

Sum=1109

Dec 27, 2021 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Dec 27, 2021; 13(12): 1828-1849
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.1828

Full Size Figure Download Figure

Figure 1 Mind map describing a practical approach to the inflammatory bowel disease patient with abnormal liver function tests. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; CE-CT: Contrast-enhancement computed tomography; CMV: Cytomegalovirus; DILI: Drug-induced liver injury; EBV: Epstein-Barr virus; GGT: Gamma-glutamyl transpeptidase; HAV: Hepatitis A virus; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HDS: Herbal and dietary supplements; HEV: Hepatitis E virus; HIV: Human immunodeficiency virus; HSV: Herpes simplex virus; MRCP: Magnetic resonance cholangiopancreatography; MRI: Magnetic resonance imaging; OTC: Over-the-counter drugs.

Citation: Mazza S, Soro S, Verga MC, Elvo B, Ferretti F, Cereatti F, Drago A, Grassia R. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World J Hepatol 2021; 13(12): 1828-1849
URL: https://www.wjgnet.com/1948-5182/full/v13/i12/1828.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i12.1828